www.fdanews.com/articles/186610-tandem-diabetes-care-gets-ce-mark-for-insulin-pump
![](https://www.fdanews.com/ext/resources/test/Device_Images6/TandemDiabetesCare_Logo.gif?t=1525128694&width=430)
Tandem Diabetes Care Gets CE Mark for Insulin Pump
April 30, 2018
A San Diego medical device company, Tandem Diabetes Care, received a CE Mark for its t:slim X2 insulin pump with Dexcom G5 mobile continuous glucose monitoring (CGM).
The device includes a large color touchscreen, watertight construction, USB connectivity and a rechargeable battery. It is the first CGM-enabled pump that lets users make treatment decisions without pricking their finger.
The company plans to launch the pump commercially in select global markets in the second half of 2018.